Physiactisome: A New Nanovesicle Drug Containing Heat Shock Protein 60 for Treating Muscle Wasting and Cachexia

Currently, no commercially available drugs have the ability to reverse cachexia or counteract muscle wasting and the loss of lean mass. Here, we report the methodology used to develop Physiactisome—a conditioned medium released by heat shock protein 60 (Hsp60)—overexpressing C2C12 cell lines enriche...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Felice, Valentina, Barone, Rosario, Trovato, Eleonora, D’Amico, Daniela, Macaluso, Filippo, Campanella, Claudia, Marino Gammazza, Antonella, Muccilli, Vera, Cunsolo, Vincenzo, Cancemi, Patrizia, Multhoff, Gabriele, Coletti, Dario, Adamo, Sergio, Farina, Felicia, Cappello, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100106/
https://www.ncbi.nlm.nih.gov/pubmed/35563712
http://dx.doi.org/10.3390/cells11091406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100106/
https://www.ncbi.nlm.nih.gov/pubmed/35563712
http://dx.doi.org/10.3390/cells11091406

Ejemplares similares